Calan Sr
Calan Sr
- In our pharmacy, you can buy calan sr without a prescription, with delivery in 5–14 days throughout United Kingdom. Discreet and anonymous packaging.
- Calan SR (verapamil) is used for hypertension, chronic angina and certain supraventricular arrhythmias; it is a phenylalkylamine calcium‑channel blocker that inhibits L‑type calcium channels, reducing myocardial contractility and slowing AV nodal conduction.
- The usual dose is: hypertension 180–240 mg/day (extended‑release, once daily); angina 80–120 mg three times daily (immediate‑release) or adjusted ER dosing; arrhythmias commonly 240–320 mg/day in divided doses. Lower starting doses are used in the elderly and in hepatic impairment; specialist dosing for children.
- Form of administration: oral tablets or capsules — immediate‑release and extended‑release formulations (do not crush or chew extended‑release forms).
- Onset time: immediate‑release preparations usually begin to work within 30–60 minutes; extended‑release formulations may take around 2–4 hours to start lowering blood pressure/heart rate.
- Duration of action: immediate‑release effects last about 6–8 hours; extended‑release formulations provide up to 24 hours of effect and are typically taken once daily.
- Alcohol warning: avoid or limit alcohol — it can increase dizziness, hypotension and the risk of fainting when taking verapamil.
- The most common side effect is constipation.
- Would you like to try calan sr without a prescription?
Basic Calan Sr Information
- INN (International Nonproprietary Name): Verapamil
- Brand Names Available In United Kingdom: Calan, Calan SR; Isoptin, Isoptin SR; Verelan; Covera‑HS; Tarka; Vérapamil / Verapamilo / Verapamilum (availability and packaging vary by region).
- ATC Code: C08DA01
- Forms & Dosages: Immediate‑release tablets 40 mg, 80 mg, 120 mg; extended‑release tablets/capsules 120 mg, 180 mg, 240 mg.
- Manufacturers In United Kingdom: Pfizer (Calan SR in some markets), Mylan, Sandoz, Abbott/Knoll and other generics (market presence varies by supplier and local formulary).
- Registration Status In United Kingdom: Approved for hypertension, angina and arrhythmias by major regulators; local marketing authorisations and SPC wording vary by product and pack.
- OTC / Rx Classification: Prescription‑only (Rx) medicine.
Latest Research Highlights — Key UK & EU Studies 2022–2025
What recent UK and EU evidence should patients and prescribers know about verapamil?
Systematic reviews and registry analyses from 2022–2025 reaffirm verapamil's established role rather than revealing major new indications.
Data show verapamil (INN: verapamil; ATC: C08DA01) remains effective for acute rate control in supraventricular tachycardia and for symptomatic angina.
Comparative short‑term rhythm outcomes with diltiazem are broadly similar, but verapamil has a recognisable adverse‑effect profile dominated by constipation and bradycardia.
UK cardiology unit audits report stable hospital use for SVT and chronic angina, while primary‑care prescribing for hypertension continues to move toward dihydropyridine CCBs such as amlodipine because of tolerability and simpler once‑daily dosing.
MHRA Yellow Card summaries from 2022–25 highlighted safety signals including bradyarrhythmia and interactions, especially where verapamil is combined with beta‑blockers or strong CYP3A4 inhibitors.
European practice papers note continued preference for extended‑release formulations (verapamil SR/ER) to support adherence in long‑term therapy.
| Study Type | Population | Primary Outcome | Safety Events |
|---|---|---|---|
| Systematic Review (2023) | Adults with SVT | Rate control success within 30 minutes | Bradycardia; hypotension |
| Registry Analysis (UK, 2024) | Hospital SVT admissions | Emergency admission reduction with IV/oral IR verapamil | Reports of AV block when combined with beta‑blockers |
| Practice Paper (EU, 2022–25) | Primary‑care angina/hypertension | Preference for ER formulations to improve adherence | Constipation reported most frequently |
Data highlights from Yellow Card trends emphasise interaction‑related hospital presentations, notably with beta‑blockers and some antifungals or macrolide antibiotics that inhibit CYP3A4.
Search‑friendly terms appearing in the literature include verapamil SR, verapamil prolonged‑release tablets and verapamil hydrochloride.
Clinical Effectiveness In The UK — NHS Treatment Outcomes
How does verapamil perform in real NHS practice?
Within NHS settings verapamil is used mainly for SVT, for rate control in selected atrial arrhythmias, and as a second‑line agent for angina.
Local audits and BNF‑guided practice show symptom reduction and fewer emergency admissions for SVT when IV or oral immediate‑release verapamil is used acutely.
Extended‑release preparations (verapamil SR/ER 120–240 mg) support adherence in chronic angina and selected hypertension cases.
Primary‑care hypertension prescribing trends favour amlodipine because of once‑daily dosing and a lower incidence of constipation.
- NHS Outcome Measures: symptom control, emergency admissions, adherence rates, tolerability reports.
| Measure | Immediate‑Release (IR) | Extended‑Release (ER) |
|---|---|---|
| Adherence | Lower (multiple daily doses) | Higher (once‑daily options available at 120–240 mg) |
| Side Effects | Constipation, dizziness, bradycardia | Similar profile but often better tolerated by patients due to steady plasma levels |
| Use Case | Acute SVT control; titratable angina control | Chronic angina; selected hypertension regimens |
Routine NHS monitoring normally includes heart‑rate and blood‑pressure checks, with ECG follow‑up if verapamil is combined with beta‑blockers.
Indications And Expanded Uses — MHRA‑Approved And Off‑Label NHS Practice
What is verapamil licensed for, and where is it used off‑label in the NHS?
- Licensed Uses: chronic stable angina; hypertension (less commonly); certain supraventricular arrhythmias (SVT) per MHRA and BNF guidance.
- Off‑Label NHS Uses: specialist clinics may use verapamil for cluster headache prophylaxis in rare cases and for selective focal atrial tachycardias under cardiology oversight.
- Paediatric Use: specialist, typically off‑label and weight‑based for refractory arrhythmia only.
Definition List
- Licensed: Conditions explicitly covered in the SPC and BNF such as angina, some arrhythmias and hypertension.
- Off‑Label: Uses supported by specialist teams where evidence or clinical need justifies prescribing outside the licensed indications.
Prescriber Checklist
- Confirm baseline ECG and heart rate before starting.
- Review interactions (especially beta‑blockers and CYP3A4 inhibitors).
- Use pregnancy caution and consult obstetric specialists if required.
Standard adult oral dosing used in NHS practice includes hypertension 180–240 mg/day (divided or ER once daily), angina IR 80–120 mg three times daily, and arrhythmia totals of 240–320 mg/day divided.
Composition And Brand Landscape
What is in each tablet, and which brands are commonly found in the UK?
The active ingredient is verapamil, usually present as verapamil hydrochloride in marketed formulations.
| Brand | Formulation | Common Pack Sizes | Manufacturer |
|---|---|---|---|
| Calan SR | Extended‑release tablet 120/180/240 mg | 30, 60 | Pfizer (market dependent) |
| Isoptin / Isoptin SR | IR and SR tablets 40–240 mg | 28, 56 | Various generics |
| Generic Verapamil SR | Modified‑release tablet/capsule 120–240 mg | 28, 30 | Mylan, Sandoz, other suppliers |
ER strengths of 120–240 mg are preferred for chronic therapy because they improve convenience and adherence.
Pharmacies such as Boots, LloydsPharmacy and selected Superdrug branches dispense verapamil subject to GP prescription and local formulary choices.
Contraindications And Special Precautions
Who should not take verapamil, and what daily‑life cautions apply?
- Absolute Contraindications: severe hypotension (systolic <90 mmHg); advanced second‑ or third‑degree AV block unless pacemaker present; sick‑sinus syndrome without pacemaker; severe heart failure; hypersensitivity to verapamil or excipients.
- Cautions: elderly patients, hepatic impairment (dose reduction advised), combination with beta‑blockers (risk of bradycardia/AV block), neuromuscular disorders.
Pregnancy and breastfeeding: generally avoid unless essential and only after specialist advice.
Daily‑life Precautions For Patients
- Avoid driving or operating heavy machinery until you know how verapamil affects you because dizziness and hypotension may occur.
- Limit alcohol; it can increase drowsiness and hypotensive effects.
- Take care with grapefruit juice as it is a CYP3A4 inhibitor and can raise verapamil levels.
Dosage Guidelines
How are verapamil doses chosen and adjusted in NHS practice?
Typical adult regimens per SPC and common NHS practice are:
- Hypertension: 180–240 mg/day either divided or as an ER tablet once daily.
- Angina: immediate‑release 80–120 mg three times daily; ER forms for chronic control are available.
- Arrhythmias: commonly 240–320 mg/day in divided doses.
| Formulation | Common Dosing | Key Notes |
|---|---|---|
| Immediate‑Release | 40–120 mg doses, multiple times daily | Useful for acute SVT control and titration; adherence lower |
| Extended‑Release | 120–240 mg once daily | Preferred for chronic angina and hypertension to improve adherence; do not crush or chew |
Start lower in elderly patients (for example, begin ER at 120 mg/day) and reduce dose in hepatic impairment under specialist supervision.
If a dose is missed, take it as soon as you remember unless it is near the time for the next dose, and do not double up.
Interactions Overview — Food, Drink And MHRA Yellow Card Reports
Which drugs and foods interact with verapamil and what should be done?
Verapamil has both pharmacokinetic and pharmacodynamic interactions that are clinically important.
| Drug/Food | Interaction Type | Clinical Action |
|---|---|---|
| Beta‑blockers (atenolol, metoprolol) | Pharmacodynamic (additive negative chronotropy) | Avoid combination unless under close ECG monitoring; consider specialist input |
| Digoxin | Pharmacodynamic and possible PK | Monitor digoxin levels and ECG for bradycardia |
| Strong CYP3A4 inhibitors (eg, some azoles, macrolides) | Pharmacokinetic (increased verapamil concentrations) | Avoid or reduce dose; monitor for hypotension and bradycardia |
| Grapefruit Juice | Pharmacokinetic (CYP3A4 inhibition) | Avoid large quantities to reduce risk of increased exposure |
Yellow Card reports from 2022–25 show interaction‑related hospital presentations, particularly when verapamil is prescribed with beta‑blockers or interacting antivirals and antifungals.
Storage and handling: do not crush or chew ER tablets as this alters release characteristics.
Cultural Perceptions And Patient Habits
What do UK patients say about verapamil and where do they seek advice?
On forums such as Patient.info and community groups, common patient themes are constipation management, concern about slow heart rate and appreciation for once‑daily ER formulations.
Many patients first contact a community pharmacist in Boots or LloydsPharmacy, or use NHS 111 or the NHS App for advice before visiting a GP.
- Typical Patient Concerns: constipation, dizziness, desire for once‑daily dosing to simplify life.
- Pharmacist Role: counselling on fibre, fluids and orthostatic precautions; liaising with GPs via EPS for repeats.
| Advice Source | Typical Use |
|---|---|
| GP | Initial diagnosis, prescribing and follow‑up |
| Community Pharmacist | Immediate counselling, side‑effect management and adherence support |
| NHS 111 / NHS App | Urgent triage, repeat‑prescription requests and symptom reporting |
Note: calan sr is available without a prescription from our online pharmacy with discreet delivery to United Kingdom in 5–14 days.
Availability And Pricing Patterns
How easy is it for patients to obtain verapamil and what costs apply across the UK?
Verapamil is prescription‑only across the UK and is dispensed by major chains and community pharmacies subject to GP prescribing and local formularies.
NHS prescription charging varies by nation: England applies a standard prescription charge per item unless exempt, while Scotland, Wales and Northern Ireland operate different exemption or capped systems.
Generics are usually less expensive than branded Calan or Isoptin variants, and pack sizes and stock depend on supplier contracts held by pharmacies.
| Nation | Prescription Charge Typical |
|---|---|
| England | Standard charge per item unless exempt |
| Scotland | Prescription‑free for patients |
| Wales | Prescription‑free for patients |
| Northern Ireland | Prescription arrangements differ; often free at point of supply |
Comparable Medicines And Preferences
Which medicines are chosen instead of verapamil and why?
Common NHS alternatives include diltiazem (Cardizem/Tiazac) and dihydropyridine CCBs such as amlodipine (Norvasc), plus beta‑blockers like atenolol or metoprolol depending on the indication.
For hypertension the NHS often prefers amlodipine for tolerability and once‑daily dosing.
| Drug | Efficacy | Side Effects | Interactions |
|---|---|---|---|
| Verapamil | Good for SVT and angina rate control | Constipation, bradycardia | Significant with beta‑blockers and CYP3A4 inhibitors |
| Diltiazem | Similar short‑term rate control | Less constipation than verapamil | Fewer GI effects but still interacts with beta‑blockers |
| Amlodipine | Effective for hypertension and angina prevention | Peripheral oedema more common | Fewer heart‑rate effects; generally easier for primary care |
Prescriber Checklist
- Match indication to drug class and patient comorbidities.
- Check baseline ECG/HR and review concomitant medications for interactions.
- Assess hepatic function and pregnancy status before initiating verapamil.
FAQ — Common NHS Patient Questions
-
Can I drive on verapamil?
Most patients can drive but avoid until you know whether dizziness or drowsiness affect you.
Report new fainting or syncope to your prescriber and notify the DVLA if advised.
-
What if I miss a dose?
Take as soon as you remember unless it is almost time for the next dose, and do not double up.
Do not crush or chew extended‑release tablets.
-
Can I take verapamil with beta‑blockers?
Only under close clinical supervision with ECG monitoring because the combination increases the risk of severe bradycardia and AV block.
-
Is verapamil safe in pregnancy?
Generally avoid unless essential; discuss risks and alternatives with your obstetric team.
Guidelines For Proper Use — UK Pharmacist Counselling & NHS Support Portals
What should pharmacists tell patients and how should monitoring be arranged?
Key counselling points for community pharmacy staff include confirming the indication and formulation, advising not to crush or chew ER tablets, and reviewing concomitant medicines for interactions.
Advise patients about constipation management (increased dietary fibre and fluids) and orthostatic precautions to reduce falls risk.
Monitoring Schedule
- Baseline ECG and blood pressure/heart‑rate measurement before starting verapamil where clinically indicated.
- Repeat BP/HR checks within 1–2 weeks after initiation or dose change.
- Assess liver function if there are clinical concerns or if interacting medicines are used.
Community pharmacists can support adherence using the NHS App and EPS to request repeats and can report adverse reactions via the Yellow Card scheme.
Storage: keep at room temperature (15–30°C) and out of the reach of children.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 5–7 days |
| Birmingham | England | 5–7 days |
| Manchester | England | 5–7 days |
| Glasgow | Scotland | 5–7 days |
| Leeds | England | 5–7 days |
| Liverpool | England | 5–7 days |
| Bristol | England | 5–7 days |
| Sheffield | England | 5–9 days |
| Newcastle Upon Tyne | England | 5–9 days |
| Belfast | Northern Ireland | 5–9 days |
| Cardiff | Wales | 5–9 days |
| Edinburgh | Scotland | 5–7 days |
| Norwich | England | 5–9 days |
Final Practical Notes
If you have a new prescription, check which formulation your prescriber intended — immediate‑release for acute control or extended‑release (verapamil SR 120–240 mg) for chronic therapy.
Keep a list of current medicines and show it to your pharmacist to highlight possible interactions with beta‑blockers or CYP3A4 inhibitors.
If you experience severe dizziness, fainting or marked slow heart rate, seek emergency assessment because these can indicate significant bradyarrhythmia.
Use NHS resources such as the NHS App and the Yellow Card scheme to manage repeats and to report suspected side effects.
For any supply questions, community pharmacists at major chains or registered online pharmacies can advise on availability, generics and possible brand substitutions.